Table of Contents
Definition / general | Essential features | Terminology | ICD coding | Epidemiology | Sites | Pathophysiology | Etiology | Clinical features | Diagnosis | Prognostic factors | Case reports | Treatment | Clinical images | Gross description | Microscopic (histologic) description | Microscopic (histologic) images | Cytology description | Positive stains | Negative stains | Molecular / cytogenetics description | Sample pathology report | Differential diagnosis | Board review style question #1 | Board review style answer #1 | Board review style question #2 | Board review style answer #2Cite this page: Polster N, Dehner C. Proliferative nodule. PathologyOutlines.com website. https://www.pathologyoutlines.com/topic/skintumormelanocyticproliferativenodule.html. Accessed December 2nd, 2024.
Definition / general
- Distinct cellular nodules of benign melanocytes that are found within and arise from a benign background nevus (typically congenital)
Essential features
- Distinct cellular nodules of melanocytes found within a benign background nevus
- Have both benign and atypical morphologies, neither of which metastasize
- Most commonly arise from congenital nevi, especially giant congenital nevi but can also be seen in acquired nevi, such as blue nevi
Terminology
- Synonyms: expansile and cellular nodules, nodular proliferations, atypical proliferative nodules (WHO) (Arch Dermatol 2004;140:83)
ICD coding
- ICD-O: 8762/1 - proliferative dermal lesion in congenital nevus
- ICD-11: 2F20.2 & XH6AH3 - congenital melanocytic nevus & proliferative dermal lesion in congenital nevus
Epidemiology
- Often present at birth or noticed within days to weeks after (Am J Surg Pathol 2004;28:1017)
- Frequently develop within first, second and third decades of life
Sites
- Proliferative nodules can occur anywhere nevi are present
- Often affect head, neck and trunk but any site can be involved (Am J Surg Pathol 2015;39:405, Am J Surg Pathol 2011;35:656)
Pathophysiology
- Thought to be result of numerical chromosomal gains and losses within an existing nevus (Am J Pathol 2002;161:1163)
- In copy number gains, causes simultaneous increased expression in genes that enhance and genes that decrease malignant potential
- In copy number losses, causes simultaneous decreased expression in genes that enhance and genes that decrease malignant potential
- Differs from melanoma, which can have selective increased or decreased expression in specific regions of chromosomes allowing for accumulation of mutations in genes that benefit growth, reproduction and spread while reducing expression of genes that inhibit these (Am J Surg Pathol 2011;35:656)
Etiology
- No predisposing factors have been described
Clinical features
- Most often seen on congenital nevi, especially giant congenital nevi but can be found in acquired nevi (Australas J Dermatol 2000;41:109)
- Found in up to 2% of newborns with congenital nevi at birth (Arch Craniofac Surg 2019;20:139)
- Can present as a morphologically distinct area within a larger nevus or can be indistinguishable from the surrounding nevus
- For example, can present as a dark, raised papule within a flat, lighter background nevus (Australas J Dermatol 2000;41:109)
- May spontaneously regress (Br J Plast Surg 2003;56:164, Am J Surg Pathol 2004;28:1017)
- Atypical proliferative nodules can uncommonly be associated with erosion and ulceration and in extremely rare cases, local tissue invasion (Arch Craniofac Surg 2019;20:139)
- Neither typical or atypical proliferative nodules metastasize (Arch Craniofac Surg 2019;20:139, Am J Surg Pathol 2011;35:656)
Diagnosis
- Diagnosis of proliferative nodule is typically made histologically (An Bras Dermatol 2017;92:231)
- Due to the striking histologic resemblance proliferative nodules can have to melanoma, a combination of spontaneous regression, molecular diagnostics and immunohistochemistry may be required to distinguish proliferative nodules from melanoma (Br J Plast Surg 2003;56:164)
Prognostic factors
- Neither benign nor atypical proliferative nodules have been known to metastasize (Am J Surg Pathol 2011;35:656)
- Atypical proliferative nodules can in very rare cases have extensive local tissue invasion (Arch Craniofac Surg 2019;20:139)
- May spontaneously regress (Br J Plast Surg 2003;56:164, Am J Surg Pathol 2004;28:1017)
Case reports
- 2 week old boy with deeply pigmented papule within a congenital nevus (Australas J Dermatol 2000;41:109)
- 5 year old girl with primary skin lesion with dural invasion (Arch Craniofac Surg 2019;20:139)
- 14 year old girl with emergence of new nodule within dark lesion on dorsum of foot (Clin Ter 2022;173:214)
Treatment
- There is little consensus for treatment of atypical proliferative nodules (Am J Surg Pathol 2011;35:656)
- Rebiopsy is reasonable if there is concern for local recurrence of a proliferative nodule (Arch Craniofac Surg 2019;20:139)
Clinical images
Gross description
- Skin shave or ellipse with a melanocytic lesion on the surface, which may or may not have a discrete nodule or macule within
Microscopic (histologic) description
- Nodular dermal melanocytic proliferation within a larger surrounding nevus
- Higher cell density than the surrounding nevus and can be more mitotically active
- Demarcation between cells of the nodule and surrounding nevus is often obvious at low power
- Cells of the nodule still appear to blend with surrounding nevus (Br J Plast Surg 2003;56:164)
- Nodules are usually found in the papillary to middle dermis but can extend into the deep dermis (Australas J Dermatol 2000;41:109)
- In rare cases they may have many mitotic figures but can later regress (Br J Plast Surg 2003;56:164)
- Can occasionally exhibit mucinosis (Am J Surg Pathol 2011;35:656)
- Benign proliferative nodule (Am J Surg Pathol 2011;35:656)
- More blended than sharp demarcation between nodule and background nevus
- No effacement of epidermis
- Mitotic activity typically ≤ 1/mm²
- Minimal pleomorphism
- Atypical proliferative nodule (Am J Surg Pathol 2011;35:656)
- Sharp demarcation between nodule and background nevus
- Usually demonstrates pleomorphism
- Usually exhibits expansile growth
- Can have many mitotic figures
- Can have nearly identical morphology to malignant melanoma
- Distinct recurring morphologic patterns (Am J Surg Pathol 2015;39:405)
- Epithelioid pattern
- Most common
- Sharply demarcated expansile nodule of epithelioid melanocytes
- Pattern can be further stratified into 3 subcategories: classic epithelioid, monotonous epithelioid surrounding blood vessels and epithelioid with Spitzoid morphology
- Nevoid melanoma-like pattern: poorly circumscribed proliferation of intermediate sized mitotically active melanocytes with moderate nuclear atypia confined to the dermis
- Blue nevus-like pattern
- Heavily pigmented melanocytes
- Can resemble epithelioid blue nevi or cellular blue nevi
- Small round blue cell pattern: coarse chromatin, high mitotic count, lack of prominent nucleoli, resembles Merkel cell carcinoma
- Combination patterns consisting of any of the above patterns combined with a rare, complex pattern, such as a neurocristic pattern or dermatofibrosarcoma protuberans-like pattern
- Other patterns, such as deep penetrating nevus-like (An Bras Dermatol 2017;92:231)
- Epithelioid pattern
Microscopic (histologic) images
Cytology description
- Cytology is not part of the work up for proliferative nodules
Positive stains
- S100
- HMB45
- MelanA
- p16 (100% of benign and atypical proliferative nodules)
- p53 (30% background nevus, 60% benign proliferative nodules, 100% atypical proliferative nodules)
- BCL2 (atypical proliferative nodules, 60%)
- CD117 (proliferative nodules typically positive, conflicting reports of background nevus positivity)
- Retained H3K27me3 expression (lost in up to 25% of primary melanomas) (Am J Surg Pathol 2018;42:701)
- Ki67 (mean of 1% in benign, 7% in atypical) (Am J Surg Pathol 2011;35:656)
- At least 1+ MIB1 staining in 50% of benign nodules and 100% in atypical nodules (Am J Surg Pathol 2004;28:1017)
- References: Am J Surg Pathol 2004;28:1017, Am J Surg Pathol 2011;35:656
Negative stains
- PRAME (may be diffusely positive in a minority of cases) (J Cutan Pathol 2021;48:1410, Am J Dermatopathol 2023;45:437)
- p21 (20% all proliferative nodules)
- BCL2 (ordinary proliferative nodules, 16%)
- CD45 (lymphocytes will stain positive)
- References: Am J Surg Pathol 2004;28:1017, Am J Surg Pathol 2011;35:656
Molecular / cytogenetics description
- Genomic hybridization can show no detectable cytogenic aberrations or whole chromosomal gains or losses (J Cutan Pathol 2021;48:1410)
- BRAF mutations detected in 34% of proliferative nodules (Am J Surg Pathol 2011;35:656)
- NRAS mutations in 48% (Am J Surg Pathol 2011;35:656)
Sample pathology report
- Skin, back, biopsy:
- Compound nevus with congenital features and focal proliferative nodule (see comment)
- Comment: There is a compound congenital nevus with good dermal maturation. Within it there is an area of greater cellularity with larger, more hyperchromatic cells. This component appears to blend into the background nevus and does demonstrate maturation. This is favored to represent a proliferative nodule.
Differential diagnosis
- Malignant melanoma:
- Can evolve from preexisting nevi, especially giant congenital nevi (Br J Plast Surg 2003;56:164)
- Genomic hybridization can show complex chromosomal aberrations, such as copy number changes, specifically partial copy number gains or losses (J Cutan Pathol 2021;48:1410)
- In a study comparing proliferative nodules and melanomas arising from congenital nevi, melanomas (Am J Surg Pathol 2015;39:405)
- Had an average mitotic count of 12.5 mitoses/mm2 compared to proliferative nodules average of 1.67 mitoses/mm2
- Are more likely to have ulceration of the overlying epidermis
- Are far less common and less likely to present as multiple lesions than proliferative nodules
- Combined melanocytic nevi:
- Composed of 2 distinct populations of melanocytes, typically a common nevus with an associated secondary nevus
- Blue nevi are the most common to present in this fashion but other nevi, such as Spitz nevi and BAP1 inactivated melanocytoma, can as well (Am J Surg Pathol 2011;35:1540)
- Blue nevus:
- Dermal proliferation of dendritic, pigmented melanocytes with small round to oval nuclei
- Spitz nevus:
- Dermal proliferation of large spindled to epithelioid cells, which are more nested superficially and extend deep as individual cells
- Can have Kamino bodies
- BAP1 inactivated melanocytoma:
- Predominately dermal based proliferation of large epithelioid melanocytes with characteristic biallelic inactivation of the BAP1 gene (Am J Surg Pathol 2012;36:818)
Board review style question #1
Which of the following describes melanocytic proliferative nodules?
- Dermal proliferation of pigmented melanocytes with dendritic morphology within a fibroblastic stroma
- Epithelioid to spindled benign melanocytic proliferation with biallelic inactivation of BAP1
- Melanocyte proliferations with cytologic atypia, invasive growth and ulceration
- Nodular proliferation of melanocytes that is distinct from and more cellular than a surrounding larger background nevus
- Proliferation of large epithelioid to spindle cells with Kamino bodies
Board review style answer #1
D. Nodular proliferation of melanocytes that is distinct from and more cellular than a surrounding larger background nevus. Proliferative nodules are nodular proliferations of melanocytes that are distinct from and more cellular than their surrounding larger background nevi. Answer B is incorrect because it describes BAP1 inactivated melanocytoma. Answer E is incorrect because it describes Spitz nevi. Answer C is incorrect because it describes invasive melanoma. Answer A is incorrect because it describes blue nevi.
Comment Here
Reference: Proliferative nodule
Comment Here
Reference: Proliferative nodule
Board review style question #2
Which of the following would more likely be seen in a benign melanocytic proliferative nodule as compared to an atypical proliferative nodule?
- Blended transition from the proliferative nodule to background nevus
- Epidermal effacement
- Expansile growth
- Many mitotic figures
- Striking nuclear pleomorphism
Board review style answer #2
A. Blended transition from the proliferative nodule to background nevus. Benign proliferative nodules tend to have a more subtle blend into their background nevi, while atypical proliferative nodules often have a sharp demarcation. Answers B - E are incorrect because they describe atypical proliferative nodules. Benign proliferative nodules tend to have minimal mitotic activity and minimal nuclear pleomorphism, while atypical proliferative nodules can have many mitotic figures, striking nuclear pleomorphism and expansile growth.
Comment Here
Reference: Proliferative nodule
Comment Here
Reference: Proliferative nodule